Market Value3,527,985,574
Total Holdings81
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
DAWN / Day One Biopharmaceuticals, Inc.
IOVA / Iovance Biotherapeutics, Inc.
SYRE / Spyre Therapeutics, Inc.
XNCR / Xencor, Inc.
BBIO / BridgeBio Pharma, Inc.
BCAX / Bicara Therapeutics Inc.
US02081GAB86 / Alphatec Holdings, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
HROW / Harrow, Inc.
KRYS / Krystal Biotech, Inc.
APGE / Apogee Therapeutics, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
INSP / Inspire Medical Systems, Inc.
EXAS / Exact Sciences Corporation
LUNG / Pulmonx Corporation
ISRG / Intuitive Surgical, Inc.
PCVX / Vaxcyte, Inc.
NBIX / Neurocrine Biosciences, Inc.
GKOS / Glaukos Corporation
REPL / Replimune Group, Inc.
KIDS / OrthoPediatrics Corp.
FDMT / 4D Molecular Therapeutics, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
RGEN / Repligen Corporation
ORKA / Oruka Therapeutics, Inc.
AMPHASTAR PHARMACEUTICALS IN / NOTE 2.000% 3/1 (03209RAB9)
CUTERA INC / NOTE 4.000% 6/0 (232109AG3)
DEXCOM INC / NOTE 0.375% 5/1 (252131AM9)
CELC / Celcuity Inc.
BSX / Boston Scientific Corporation
GH / Guardant Health, Inc.
US64049MAB63 / NeoGenomics Inc
TMDX / TransMedics Group, Inc.
ALEC / Alector, Inc.
APLS / Apellis Pharmaceuticals, Inc.
NVCR / NovoCure Limited
US46333XAH17 / CONV. NOTE
ARVN / Arvinas, Inc.
KNSA / Kiniksa Pharmaceuticals International, plc
CGEM / Cullinan Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
ZURA / Zura Bio Limited
AKRO / Akero Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
US252131AK39 / CONV. NOTE
SRPT / Sarepta Therapeutics, Inc.
OM / Outset Medical, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
LIVN / LivaNova PLC
ETNB / 89bio, Inc.
LBPH / Longboard Pharmaceuticals, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
IMTX / Immatics N.V.
US761299AB20 / Retrophin Inc Bond
LXEO / Lexeo Therapeutics, Inc.
US10806XAD49 / BRIDGEBIO PHARMA INC
LXRX / Lexicon Pharmaceuticals, Inc.
NVRO / Nevro Corp.
PODD / Insulet Corporation
US232109AD04 / Cutera Inc
US45784PAK75 / CONV. NOTE
US405024AB67 / Haemonetics Corp
FNA / Paragon 28, Inc.
HLVX / HilleVax, Inc.
ELEV / Elevation Oncology, Inc.
US670704AJ40 / NuVasive, Inc.
OCUL / Ocular Therapeutix, Inc.
JSPR / Jasper Therapeutics, Inc.
AVDL / Avadel Pharmaceuticals plc
RLAY / Relay Therapeutics, Inc.
US40131MAB54 / CONVERTIBLE ZERO
US10806XAB82 / Bridgebio Pharma, Inc.
SKIN / SkinHealth Systems Inc.
KROS / Keros Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
TMO / Thermo Fisher Scientific Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
PEN / Penumbra, Inc.
IRTC / iRhythm Holdings, Inc.
ATEC / Alphatec Holdings, Inc.
VERV / Verve Therapeutics, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
CGON / CG Oncology, Inc.
VKTX / Viking Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ALGN / Align Technology, Inc.
CSTL / Castle Biosciences, Inc.
DNTH / Dianthus Therapeutics, Inc.
DXCM / DexCom, Inc.